Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations

The recent discovery of relevant biomarkers has reshaped our approach to therapy selection for patients with non-small cell lung cancer. The unprecedented outcomes demonstrated with tyrosine kinase inhibitors in molecularly defined cohorts of patients has underscored the importance of genetic profil...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Levy, Benjamin P., Chioda, Marc D., Herndon, Dana, Longshore, John W., Mohamed, Mohamed, Ou, Sai-Hong Ignatius, Reynolds, Craig, Singh, Jaspal, Wistuba, Ignacio I., Bunn, Paul A., Hirsch, Fred R.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Lung Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4591939/
https://ncbi.nlm.nih.gov/pubmed/26330460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados